Compare Ginkgo Bioworks Holdings Inc (DNA) vs Jones Lang LaSalle Inc (JLL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs Jones Lang LaSalle Inc — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.58 (market cap $505.73M), while Jones Lang LaSalle Inc trades at $365.99 (market cap $16.72B). The key difference: Jones Lang LaSalle Inc is far larger — about 33.1× Ginkgo Bioworks Holdings Inc's market cap, and Jones Lang LaSalle Inc is trading nearer its 52-week high, Ginkgo Bioworks Holdings Inc nearer its low. Which is the better fit depends on your goals.
| DNA | JLL | |
|---|---|---|
Market Cap | $505.73M | $16.72B |
Sector | Health | Real Estate |
52-Week High | $16.14 | $373.24 |
52-Week Low | $5.48 | $280.16 |
Enterprise Value | $607.68M | $19.48B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About Jones Lang LaSalle Inc
Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $70 billion for clients across diverse public and private real estate strategies.
Read more on JLL →
